Home/Filings/4/0001567619-23-004546
4//SEC Filing

Lock Kenneth A. 4

Accession 0001567619-23-004546

CIK 0001787306other

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 6:57 PM ET

Size

7.5 KB

Accession

0001567619-23-004546

Insider Transaction Report

Form 4
Period: 2023-03-02
Lock Kenneth A.
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2023-03-02+21,00064,260 total
  • Award

    Stock Option (Right to Buy)

    2023-03-02+55,80055,800 total
    Exercise: $15.82Exp: 2033-03-02Common Stock (55,800 underlying)
Footnotes (2)
  • [F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting. 25% of the RSUs vest annually on March 2 of each year, beginning March 2, 2024, subject to the Reporting Person's continued service to the Issuer.
  • [F2]1/48th of the shares subject to the option vest on each monthly anniversary measured from March 2, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer..

Documents

1 file

Issuer

Arcutis Biotherapeutics, Inc.

CIK 0001787306

Entity typeother

Related Parties

1
  • filerCIK 0001801047

Filing Metadata

Form type
4
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 6:57 PM ET
Size
7.5 KB